March 7, 2010
Market Wire - Cannasat Therapeutics Reports Results for the Year Ended December 31, 2009
March 5, 2010 — Cannasat Therapeutics Inc. (TSX VENTURE: CTH), a specialty clinical development pharmaceutical company targeting CNS diseases, today announced its…
More: continued here













































Leave a Comment